Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
1.
Article in Chinese | WPRIM | ID: wpr-877598

ABSTRACT

OBJECTIVE@#To observe the clinical therapeutic effect of electroacupuncture (EA) combined with tamsulosin hydrochloride sustained release capsule on chronic prostatitis (CP) of damp and heat stasis.@*METHODS@#A total of 70 patients with CP of damp and heat stasis were randomized into an acupuncture plus medication group (35 cases, 4 cases dropped off) and a medication group (35 cases, 5 cases dropped off). In the medication group, tamsulosin hydrochloride sustained release capsule was given orally, 0.2 mg a time, once each night. On the basis of treatment in the medication group, EA was applied at Guanyuan (CV 4), Sanyinjiao (SP 6) and Yinglingquan (SP 9), with disperse-dense wave, 5 mA in intensity for 30 min. Treatment for 30 days was as one course, and totally 3 courses were required in both groups. Before treatment, 1, 2, 3 months into treatment and at the follow-up of 2 months after treatment, the TCM syndrome score and National Institutes of Health chronic prostatitis symptom index (NIH-CPSI) score were observed, and the clinical efficacy was evaluated in both groups.@*RESULTS@#Compared before treatment, the TCM syndrome scores of 3 months into treatment and follow-up were decreased in the acupuncture plus medication group (@*CONCLUSION@#Acupuncture combined with medication can improve the clinical symptoms in patients with CP of damp and heat stasis, and its therapeutic effect is superior to simple western medication.


Subject(s)
Acupuncture Points , Acupuncture Therapy , Chronic Disease , Hot Temperature , Humans , Male , Prostatitis/drug therapy , Treatment Outcome
2.
Medicina (B.Aires) ; 80(3): 241-247, jun. 2020.
Article in Spanish | LILACS | ID: biblio-1125075

ABSTRACT

La segunda parte del Consenso Argentino Intersociedades de Infección Urinaria incluye el análisis de situaciones especiales. En pacientes con sonda vesical se debe solicitar urocultivo solo cuando hay signo-sintomatología de infección del tracto urinario, antes de instrumentaciones de la vía urinaria o como control en pacientes post-trasplante renal. El tratamiento empírico recomendado en pacientes sin factores de riesgo es cefalosporinas de tercera generación o aminoglucósidos. Las infecciones del tracto urinario asociadas a cálculos son siempre consideradas complicadas. En caso de obstrucción con urosepsis, deberá realizarse drenaje de urgencia por vía percutánea o ureteral. En pacientes con stents o prótesis ureterales, como catéteres doble J, el tratamiento empírico deberá basarse en la epidemiología, los antibióticos previos y el estado clínico. Antes del procedimiento de litotricia extracorpórea se recomienda pesquisar la bacteriuria y, si es positiva, administrar profilaxis antibiótica según el antibiograma. Cefalosporinas de primera generación o aminoglúcosidos son opciones válidas. Se recomienda aplicar profilaxis antibiótica con cefalosporinas de primera generación o aminoglúcosidos antes de la nefrolitotomía percutánea. La biopsia prostática trans-rectal puede asociarse a complicaciones infecciosas, como infecciones del tracto urinario o prostatitis aguda, principalmente por Escherichia coli u otras enterobacterias. En pacientes sin factores de riesgo para gérmenes multirresistentes y urocultivo negativo se recomienda realizar profilaxis con amikacina o ceftriaxona endovenosas. En pacientes con urocultivo positivo, se realizará profilaxis según antibiograma, 24 horas previas a 24 horas post-procedimiento. Para el tratamiento dirigido de la prostatitis post-biopsia trans-rectal, los carbapenémicos durante 3-4 semanas son el tratamiento de elección.


The second part of the Inter-Society Argentine Consensus on Urinary Tract Infection (UTI) includes the analysis of special situations. In patients with urinary catheter, urine culture should be requested only in the presence of UTI symptomatology, before instrumentation of the urinary tract, or as a post-transplant control. The antibiotics recommended for empirical treatment in patients without risk factors are third-generation cephalosporins or aminoglycosides. UTIs associated with stones are always considered complicated. In case of obstruction with urosepsis, an emergency drainage should be performed via a percutaneous nefrostomy or ureteral stenting. In patients with stents or ureteral prostheses, such as double J catheters, empirical treatment should be based on epidemiology, prior antibiotics, and clinical status. Before the extracorporeal lithotripsy procedure, bacteriuria should be investigated and antibiotic prophylaxis should be administered in case of positive result, according to the antibiogram. First generation cephalosporins or aminoglycosides are valid alternatives. The use of antibiotic prophylaxis with first-generation cephalosporins or aminoglycosides before percutaneous nephrolithotomy is recommended. Transrectal prostatic biopsy can be associated with infectious complications, such as UTI or acute prostatitis, mainly due to Escherichia coli or other enterobacteria. In patients without risk factors for multiresistant bacteria and negative urine culture, prophylaxis with intravenous amikacin or ceftriaxone is recommended. In patients with positive urine culture, prophylaxis will be performed according to the antibiogram, from 24 hours before to 24 hours post-procedure. For the targeted treatment of post-transrectal biopsy prostatitis, carbapenems for 3-4 weeks are the treatment of choice.


Subject(s)
Humans , Male , Female , Urinary Tract Infections/etiology , Urinary Tract Infections/drug therapy , Consensus , Anti-Infective Agents, Urinary/therapeutic use , Argentina , Prostatitis/etiology , Prostatitis/drug therapy , Lithotripsy/adverse effects , Stents/adverse effects , Risk Factors , Nephrolithiasis/complications , Urinary Catheters/adverse effects , Nephrolithotomy, Percutaneous/adverse effects
3.
Medicina (B.Aires) ; 80(3): 229-240, jun. 2020. tab
Article in Spanish | LILACS | ID: biblio-1125074

ABSTRACT

La Sociedad Argentina de Infectología y otras sociedades científicas han actualizado estas recomendaciones utilizando, además de información internacional, la de un estudio multicéntrico prospectivo sobre infecciones del tracto urinario del adulto realizado en Argentina durante 2016-2017. La bacteriuria asintomática debe ser tratada solo en embarazadas, a quienes también se las debe investigar sistemáticamente; los antibióticos de elección son nitrofurantoína, amoxicilina, amoxicilina-clavulánico, cefalexina y trimetoprima-sulfametoxazol. Ante procedimientos que impliquen lesión con sangrado del tracto urinario se recomienda solicitar urocultivo para pesquisar bacteriuria asintomática, y, si resultara positivo, administrar antimicrobianos según sensibilidad desde inmediatamente antes hasta 24 horas luego de la intervención. En mujeres, la cistitis puede ser tratada con nitrofurantoina, cefalexina, o fosfomicina y no se recomienda usar trimetoprima-sulfametoxazol o fluoroquinolonas; en pielonefritis puede emplearse ciprofloxacina, cefixima o cefalexina si el tratamiento es ambulatorio o ceftriaxona, cefazolina o amikacina si es hospitalario. En los hombres, las infecciones del tracto urinario se consideran siempre complicadas. Se recomienda tratamiento con nitrofurantoina o cefalexina por 7 días, o bien monodosis con fosfomicina. Para la pielonefritis en hombres se sugiere ciprofloxacina, ceftriaxona o cefixima si el tratamiento es ambulatorio y ceftriaxona o amikacina si es hospitalario. Se sugiere tratar las prostatitis bacterianas agudas con ceftriaxona o gentamicina. En cuanto a las prostatitis bacterianas crónicas, si bien su tratamiento de elección hasta hace poco fueron las fluoroquinolonas, la creciente resistencia y ciertas dudas sobre la seguridad de estas drogas obligan a considerar el uso de alternativas como fosfomicina.


The Argentine Society of Infectious Diseases and other scientific societies have updated these recommendations based on data on urinary tract infections in adults obtained from a prospective multicenter study conducted in Argentina during 2016-2017. Asymptomatic bacteriuria should be treated only in pregnant women, who should also be systematically investigated; the antibiotics of choice are nitrofurantoin, amoxicillin, clavulanic/amoxicillin, cephalexin and trimethoprim-sulfamethoxazole. In procedures involving injury to the urinary tract with bleeding, it is recommended to request urine culture and, in the presence of bacteriuria, antimicrobial treatment according to sensitivity should be prescribed from immediately before up to 24 hours after the intervention. In women, cystitis can be treated with nitrofurantoin, cephalexin or fosfomycin, while trimethoprim-sulfamethoxazole and fluoroquinolones are not recommended; pyelonephritis can be treated with ciprofloxacin, cefixime or cephalexin in ambulatory women or ceftriaxone, cefazolin or amikacin in those who are hospitalized. In men, urinary tract infections are always considered complicated; nitrofurantoin or cephalexin are recommended for 7 days, alternatively fosfomycin should be given in a single dose. In men, ciprofloxacin, ceftriaxone or cefixime are suggested for pyelonephritis on ambulatory treatment whereas ceftriaxone or amikacin are recommended for hospitalized patients. Acute bacterial prostatitis can be treated with ceftriaxone or gentamicin. Fluoroquinolones were the choice treatment for chronic bacterial prostatitis until recently; they are no longer recommended due to the increasing resistance and recent concerns regarding the safety of these drugs; alternative antibiotics such as fosfomycin are to be considered.


Subject(s)
Humans , Male , Female , Pregnancy , Argentina , Urinary Tract Infections/drug therapy , Consensus , Anti-Infective Agents, Urinary/therapeutic use , Prostatitis/diagnosis , Prostatitis/drug therapy , Pyelonephritis/diagnosis , Pyelonephritis/drug therapy , Urinary Tract Infections/diagnosis , Prospective Studies , Cystitis/diagnosis , Cystitis/drug therapy
4.
Int. braz. j. urol ; 44(1): 81-85, Jan.-Feb. 2018. tab
Article in English | LILACS | ID: biblio-892946

ABSTRACT

ABSTRACT Objective To The standard technique for obtaining a histologic diagnosis of prostatic carcinomas is transrectal ultrasound guided prostate biopsy. Acute prostatitis which might develop after prostate biopsy can cause periprostatic inflammation and fibrosis. In this study, we performed a retrospective review of our database to determine whether ABP history might affect the outcome of RP. Materials and Methods 441 RP patients who were operated in our clinic from 2002 to 2014 were included in our study group. All patients' demographic values, PSA levels, biopsy and radical prostatectomy specimen pathology results and their perioperative/ postoperative complications were evaluated. Results There were 41 patients in patients with acute prostatitis following biopsy and 397 patients that did not develop acute prostatitis. Mean blood loss, transfusion rate and operation period were found to be significantly higher in ABP patients. Hospitalization period and reoperation rates were similar in both groups. However, post-op complications were significantly higher in ABP group. Conclusion Even though it does not affect oncological outcomes, we would like to warn the surgeons for potential complaints during surgery in ABP patients.


Subject(s)
Humans , Male , Prostatectomy/methods , Prostatic Neoplasms/surgery , Prostatitis/etiology , Image-Guided Biopsy/adverse effects , Prostatic Neoplasms/pathology , Prostatitis/drug therapy , Acute Disease , Retrospective Studies , Treatment Outcome , Ultrasonography, Interventional , Middle Aged
5.
Int. braz. j. urol ; 40(3): 356-366, may-jun/2014. tab
Article in English | LILACS | ID: lil-718254

ABSTRACT

Purpose To evaluate the association between prostatic inflammation and lower urinary tract symptoms (LUTS), and to identify the effects of prostatic inflammation on the treatment with an alpha blocker. Materials and Methods 111 Participants who were aged ≥ 50 years, the presence of LUTS (maximal flow rate < 20 m/s, IPSS ≥ 11), and an elevated PSA level (3-20ng/mL) were treated with tamsulosin 0.2mg once daily for 3 months after prostate biopsies. Prostatic inflammation was scored as none (0), mild (I), moderate (II), or marked (III). LUTS parameters including urine flow rates, IPSS, PSA, and prostate volume were evaluated. Results Inflammation grading resulted in 25, 60, and 26 patients that were grade 0, I, and II, respectively. Lower grade inflammation was related to higher urine flow rate at baseline. Patients with higher inflammation grades had larger prostate volumes, larger total and transitional zone volumes, and higher PSA levels. Overall, urine flow rates and residual urine volume were improved after 3 months of alpha blocker therapy. Eighty percent of patients with grade 0 inflammation, 73% of patients with grade I inflammation, and 92.3% of patients with grade II inflammation showed improvement of LUTS after treatment. Longer duration of treatment was related to a decreased chance of improvement of LUTS. Patients with increased IPSS voiding subscales could be predictive of improvement of LUTS. Conclusions Patients with high grade inflammation had lower flow rates and higher prostatic volumes than patients with low grade inflammation. Inflammation grade did not affect the outcomes of alpha blocker treatment. .


Subject(s)
Aged , Humans , Male , Middle Aged , Adrenergic alpha-1 Receptor Antagonists/therapeutic use , Lower Urinary Tract Symptoms/drug therapy , Prostatic Hyperplasia/drug therapy , Prostatitis/drug therapy , Sulfonamides/therapeutic use , Biopsy , Disease Progression , Lower Urinary Tract Symptoms/pathology , Organ Size , Predictive Value of Tests , Prostate-Specific Antigen/blood , Prostatic Hyperplasia/pathology , Prostatitis/complications , Prostatitis/pathology , Severity of Illness Index , Statistics, Nonparametric , Treatment Outcome
6.
Int. braz. j. urol ; 39(2): 214-221, Mar-Apr/2013. tab, graf
Article in English | LILACS | ID: lil-676271

ABSTRACT

Objective To evaluate the efficacy of Profluss® on prostatic chronic inflammation (PCI). Materials and Methods We prospectively enrolled 168 subjects affected by LUTS due to bladder outlet obstruction submitted to 12 cores prostatic biopsy for suspected prostate cancer + 2 cores collected for PCI valuation. First group consisted of 108 subjects, with histological diagnosis of PCI associated with BPH and high grade PIN and/or ASAP, randomly assigned to 1:1 ratio to daily Profluss® (group I) for 6 months or to control group (group Ic). Second group consisted of 60 subjects, with histological diagnosis of BPH, randomly assigned to 1:1 ratio to daily Profluss® + α-blockers treatment (group II) for 3 months or to control group (group IIc). After 6 months first group underwent 24 cores prostatic re-biopsy + 2 cores for PCI while after 3 months second group underwent two-cores prostatic for PCI. Specimens were evaluated for changes in inflammation parameters and for density of T-cells (CD3, CD8), B-cells (CD20) and macrophages (CD68). Results At follow-up there were statistical significant reductions of extension and grading of flogosis, mean values of CD20, CD3, CD68 and mean PSA value in group I compared to Ic, while extension and grading of flogosis in group II were inferior to IIc but not statistical significant. A statistically significant reduction in the density of CD20, CD3, CD68, CD8 was demonstrated in group II in respect to control IIc. Conclusions Serenoa repens+Selenium+Lycopene may have an anti-inflammatory activity that could be of interest in the treatment of PCI in BPH and/or PIN/ASAP patients. .


Subject(s)
Aged , Humans , Male , Middle Aged , Carotenoids/therapeutic use , Plant Extracts/therapeutic use , Prostatic Hyperplasia/drug therapy , Prostatitis/drug therapy , Serenoa , Selenium/therapeutic use , Anti-Inflammatory Agents/therapeutic use , B-Lymphocytes , Biopsy , Italy , Macrophages , Neoplasm Grading , Prospective Studies , Prostate-Specific Antigen/blood , Prostatic Hyperplasia/pathology , Prostatitis/pathology , T-Lymphocytes , Treatment Outcome , Urinary Bladder Neck Obstruction/drug therapy , Urinary Bladder Neck Obstruction/etiology
8.
Int. braz. j. urol ; 32(2): 181-186, Mar.-Apr. 2006. graf
Article in English | LILACS | ID: lil-429016

ABSTRACT

INTRODUCTION: The exact mechanism of chronic nonbacterial prostatitis has not been yet elucidated and the outcome with the current management is dismal. In this trial, we studied the effect of allopurinol in the treatment of this disease. MATERIALS AND METHODS: In this randomized double blind controlled trial, a calculated sample size of 56 were grouped into "intervention group" who received allopurinol (100 mg tds for 3 months) with ofloxacin (200 mg tds) for 3 weeks (n = 29) and "control group" who received placebo tablets with ofloxacin (n = 27). PatientsÆ scores based on the National Institute of Health Chronic Prostatitis Symptom Score were recorded before therapy and then every month during the study. A four-glass study was performed before intervention and after 3 months. RESULTS: The 2 groups were similar regarding outcome variables. In the first month of study, a significant but similar improvement in symptom scores was observed in both groups. Microscopic examination of prostate massage and post-massage samples were also similar in both groups. No side effects due to allopurinol were observed in patients. CONCLUSION: We did not find any advantage for allopurinol in the management of chronic prostatitis versus placebo in patients receiving routine antibacterial treatment.


Subject(s)
Adult , Humans , Male , Allopurinol/therapeutic use , Anti-Infective Agents, Urinary/therapeutic use , Antimetabolites/therapeutic use , Ofloxacin/therapeutic use , Prostatitis/drug therapy , Allopurinol/administration & dosage , Anti-Infective Agents, Urinary/administration & dosage , Antimetabolites/administration & dosage , Chronic Disease , Double-Blind Method , Drug Therapy, Combination , Ofloxacin/administration & dosage
9.
LMJ-Lebanese Medical Journal. 2000; 48 (4): 278-282
in English | IMEMR | ID: emr-54478

ABSTRACT

Urinary tract infections [UTIs] are commonly encountered in medical practice and range from asymptomatic bacteruria to acute pyelonephritis. Enterobacteriaceae with E. coli being the most prevalent, are responsible for most commonly acquired uncomplicated UTIs and usually respond promptly to oral antibiotics. In contradistinction, more resistant pathogens cause nosocomially acquired infections which often require parenteral antibiotic therapy. Patients with acute bacterial prostatitis, usually caused by Enterobacteriaceae present with a tender prostate gland and respond promptly to antibiotic therapy. Chronic bacterial prostatitis on the other hand, is a subacute infection characterized by recurrent episodes of bacterial UTI where the patient presents with vague symptoms of pelvic pain and voiding problems. Treatment is protracted and may be frustrating. Nonbacterial prostatitis and chronic pelvic pain syndrome produce symptoms similar to those of chronic bacterial prostatitis. Treatment is not well defined due to their uncertain etiologies. Most episodes of catheter associated bacteruria are asymptomatic, where less than 5% will be complicated by bacteremia. The use of systemic antibiotics for treatment or prevention of bacteruria is not recommended, particularly in the geriatric age group, since it helps select for resistant organisms. Prevention thus remains the best option to control it. Few patients without catheters who have asymptomatic bacteruria develop serious complications and therefore routine antimicrobial therapy is not justified with only two exceptions: before urologic surgery and during pregnancy


Subject(s)
Humans , Urinary Tract Infections/diagnosis , Urinary Tract Infections/classification , Prostatitis/drug therapy , Cystitis , Urethritis , Pyelonephritis , Bacteriuria
10.
Pakistan Journal of Medical Sciences. 2000; 16 (4): 251-254
in English | IMEMR | ID: emr-115444

ABSTRACT

Urinary Tract Infections in adults are quite commonly encountered in General Practice. It remains a significant cause of morbidity. Categorization of the infection by clinical syndrome and by host helps the physician to determine the appropriate diagnostic and management strategies. Clinical judgement should dictate whether urine culture is needed or not. The most effective therapy for an uncomplicated infection is a three-day course of trimethoprim-sulfomethoxozole [Co-Trimoxazole]. Nitrofurantoin can also be used. Complicated infections require a more prolonged course of therapy. Quinolones or third generation cephalosporins can be used for at least 10 to 14 days


Subject(s)
Humans , Male , Female , Urinary Tract Infections/drug therapy , Bacteriuria/diagnosis , Cystitis/diagnosis , Cystitis/drug therapy , Prostatitis/diagnosis , Prostatitis/drug therapy , Pyelonephritis/diagnosis , Pyelonephritis/drug therapy
11.
Bol. Col. Mex. Urol ; 14(2): 94-6, mayo-ago. 1997. tab
Article in Spanish | LILACS | ID: lil-217353

ABSTRACT

Se realizó un estudio multicéntrico, prospectivo y comparativo con distribución al azar para comparar la eficacia y la seguridad de lomefloxacino (LMF) con la de trimetoprim/sulfametoxazol (TMP/SMX) en el tratamiento de la prostatitis bacteriana crónica. El estudio se efectuó en tres centros hospitalarios, y abarcó a un total de 30 pacientes adultos del sexo masculino con diagnósticos clínicos y bacteriológico confirmados. Los pacientes se distribuyeron al azar para recibir LMF a la dosis de 400 mg una vez al día (n = 15), o TMP/SMX a la de 160/800 mg dos veces al día (n = 15) durante seis semanas. Se valoraron los aspectos de seguridad y eficacia antes del tratamiento, durante el mismo y una vez terminado éste mediante cultivos de orina pruebas de laboratorio y valoración clínica, incluso hasta dos y cuatro meses después del tratamiento. Se logró erradicación bacteriológica en 92.3 por ciento de los pacientes tratados. con LMF y en 84.6 por ciento de los que recibieron TMP/SMX (p> 0.05). Se logró un buen resultado clínico en 100 por ciento de los pacientes que recibieron LMF o TMP/SMX. Ambas evaluaciones se realizaron cinco a nueve días después de terminar el tratamiento. Los agentes patógenos que con mayor frecuencia se aislaron fueron Escherichia coli (43.3 por ciento), estafilococo coagulasa negativo (20 por ciento), Staphylococcus saprophiticus (13.3 por ciento) y Enterococcus sp. (13.3 por ciento). Los efectos adversos se consideraron leves, y los experimentaron un paciente que recibió LMF y dos que tomaron TMP/SMX


Subject(s)
Humans , Male , Adult , Bacterial Infections/drug therapy , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Drug Resistance, Microbial , Prostatitis/drug therapy , Prostatitis/microbiology , Quinolones/therapeutic use , Urine/microbiology
12.
Medicina (Ribeiräo Preto) ; 28(4): 742-9, out.-dez. 1995.
Article in Portuguese | LILACS | ID: lil-184005

ABSTRACT

Os autores fazem uma abordagem prática sobre o diagnóstico e o tratamento de pacientes com infeccao aguda do trato urogenital. Säo apresentadas as situaçöes mais comuns relacionadas à infecçäo do trato urinário baixo e do rim, assim como algumas das infecçöes sexualmente transmissíveis. Procurou-se, em cada situaçäo, comentar sobre os agentes etiológicos mais freqüentes, bem como orientar a solicitaçäo de exames subsidiários pertinentes para a confirmaçäo do diagnóstico, para a identificaçäo de complicaçäo ou de fatores predisponentes. Recomendou-se, ainda, a terapia específica mais usada para cada caso, näo só para combater os agentes infecciosos mais também os fatores predisponentes e as complicaçöes


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Urinary Tract Infections , Varicocele , Acute Disease , Causality , Cystitis/diagnosis , Cystitis/drug therapy , Epididymitis/diagnosis , Epididymitis/drug therapy , Fournier Gangrene/drug therapy , Nephritis, Interstitial/drug therapy , Prostatitis/diagnosis , Prostatitis/drug therapy , Urethritis/drug therapy
14.
Bol. Col. Mex. Urol ; 11(1): 51-3, ene.-abr. 1994. tab
Article in Spanish | LILACS | ID: lil-135231

ABSTRACT

Se presentan 34 pacientes con diagnóstico de prostatitis crónica, previamente tratados con terapia convencional sin resultado. Se les realizó inyección intraprostática de cloranfenicol en combinación con dexametasona por vía transuretral. Los resultados fueron exelentes en 30 pacientes, buenos en tres y malos en uno. La respuesta al tratamiento fue uniforme, por lo que se considera que es una buena alternativa para los casos que no reaccionan al tratamiento general


Subject(s)
Humans , Male , Adult , Chloramphenicol/administration & dosage , Dexamethasone/administration & dosage , Chronic Disease/drug therapy , Prostatitis/drug therapy , Chloramphenicol/pharmacology , Dexamethasone/pharmacology , Dexamethasone/therapeutic use
15.
Rev. mex. urol ; 52(6): 166-9, nov.-dic. 1992. ilus, tab
Article in Spanish | LILACS | ID: lil-118456

ABSTRACT

Se realizó un estudio prospectivo de noviembre de 1990 a octubre de 1991, en el que se incluyeron 24 pacientes con prostatitis bacteriana crónica como afección única y no complicada, que fueron atendidos la primera vez en la consulta externa. Se encontraron antecedentes clínicos mayores de seis meses de evolución que se corroboraron por medio de cultivos de orina y secreción prostárica con la técnica de Stamey . Se trataron con cefazolina y gentamicina intraprostática por vía transuretral y en forma ambulatoria. La edad de los pacientes fluctuó entre 18 y 45 años. El agente patógeno más frecuente fue Staphylococcus aureus coagulasa positivo, sensible a cefazolina. Se comunican los datos encontrados en la anamnesis. Se obtuvo éxito de curación en 79.1 porciento y fueron necesarias de dos a cuatro aplicaciones, con un promedio de tratamiento de cuatro meses.


Subject(s)
Humans , Male , Child , Adolescent , Adult , Middle Aged , Anti-Infective Agents, Local/therapeutic use , Anti-Bacterial Agents/therapeutic use , Bacterial Infections/drug therapy , Prostatitis/drug therapy
17.
Rev. chil. urol ; 51(2): 169-71, 1988. tab
Article in Spanish | LILACS | ID: lil-69981

ABSTRACT

Se presenta una serie de 18 prostatitis bacterianas y 21 prostatitis no bacterianas tratadas durante 30 dias con Kelfiprin (R). Se reportan resultados exelentes o buenos en el 94% de las prostatitis bacterianas y en el 29% de las no bacterianas


Subject(s)
Adult , Middle Aged , Humans , Male , Prostatitis/drug therapy , Sulfalene/therapeutic use , Trimethoprim/therapeutic use , Prostatitis/diagnosis , Prostatitis/etiology
20.
Revue Marocaine de Medecine et Sante. 1984; 6 (3-4): 95-97
in French | IMEMR | ID: emr-5118

ABSTRACT

Antibiotic treatment of urinary tract infections is based upon natural history and clinical signs of the infection. The epidemiological, the bacteriological and pharmacological data are reviewed and the treatment of the major clinical situations is discussed


Subject(s)
Humans , Cystitis/drug therapy , Acute Disease , Chronic Disease , Pyelonephritis/drug therapy , Pregnancy , Prostatitis/drug therapy , Anti-Bacterial Agents
SELECTION OF CITATIONS
SEARCH DETAIL